A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

Premature Ejaculation Clinical Trial

Official title:

A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04235192
• Other study ID #: 4222018004
• Status: Recruiting
• Start date: July 31, 2019
• Est. completion date: October 1, 2020

Study information

• Verified date: January 2020
• Source: Xijing Hospital
• Contact: Jianlin Yuan, doctor
• Phone: +86-136-0912-3155
• Email: jianliny[@]fmmu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1340
• Est. completion date: October 1, 2020
• Est. primary completion date: August 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• 1) case group

1. 18-64 years old, regular sexual life > 6 months;

2. Self-report of premature ejaculation;

3. Able to complete questionnaires and scale scores independently. 2) control group

1. 18-64 years old, regular sexual life > 6 months;

2. Both partners are satisfied with their sexual life;

3. Able to complete questionnaires and scale scores independently.

Exclusion Criteria:

• 1) case group

1. Those who are unable to have sex due to genital malformation;

2. Patients with serious cardiovascular and cerebrovascular diseases;

3. Severe mental disorders (history of epilepsy, mania, etc.);

4. Have a history of brain trauma;

5. People with a long history of substance abuse. 2) control group

1. Patients with a history of mental illness;

2. Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants, triazolidine antidepressants, tramadol and sedatives

Related Conditions & MeSH terms

• Premature Birth
• Premature Ejaculation

Locations

Country	Name	City	State
China	Xijing Hospital, Fourth Military Medical University	Xi'an	Shaanxi

Sponsors (6)

Lead Sponsor	Collaborator
Xijing Hospital	First Affiliated Hospital Xi'an Jiaotong University, Northwest Women's and Children's Hospital, Shaanxi Armed Police Corps Hospital, Shaanxi Provincial People's Hospital, Xi'an No.3 Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IELT	Intra-vaginal Ejaculation Latency Time	Within 6 months